Impact of adding pertuzumab to trastuzumab plus chemotherapy in neoadjuvant treatment of HER2 positive breast cancer patients: a multicenter real-life HER2PATH study

Bilici, Ahmet; Olmez, Omer Fatih; Kaplan, Muhammed Ali; Oksuzoglu, Berna; Sezer, Ahmet; Karadurmus, Nuri; Cubukcu, Erdem; Sendur, Mehmet Ali Nahit; Aksoy, Sercan; Erdem, Dilek; Basaran, Gul; Cakar, Burcu; Shbair, Abdallah T. M.; Arslan, Cagatay; Sumbul, Ahmet Taner; Sezgin Goksu, Sema; Karadag, Ibrahim; Cicin, Irfan; Gumus, Mahmut; Selcukbiricik, Fatih; Harputluoglu, Hakan; Demirci, Umut

doi:10.1080/0284186X.2023.2202330

Impact of adding pertuzumab to trastuzumab plus chemotherapy in neoadjuvant treatment of HER2 positive breast cancer patients: a multicenter real-life HER2PATH study

Files

Impact of adding pertuzumab to trastuzumab plus chemotherapy in neoadjuvant treatment of HER2 positive breast cancer patients a multicenter real-life HER2PATH study.pdf (2.09 MB)

Date

2023

Authors

Sendur, Mehmet Ali Nahit

Aksoy, Sercan

Erdem, Dilek

dc.identifier.doi

10.1080/0284186X.2023.2202330

dc.identifier.other

WOS:000971681800001

Publisher

Medical Journal Sweden AB

DOI

10.1080/0284186X.2023.2202330

Keywords

HER2 protein positive , breast cancer , neoadjuvant treatment , pertuzumab , trastuzumab , event\\-free survival , relapse , real\\-word evidence

URI

https://openaccess.acibadem.edu.tr/handle/11443/6477

Collections

WOS

Full item page

Impact of adding pertuzumab to trastuzumab plus chemotherapy in neoadjuvant treatment of HER2 positive breast cancer patients: a multicenter real-life HER2PATH study

Files

Date

Authors

Journal Title

Journal ISSN

Volume Title

dc.identifier.issn

dc.identifier.doi

dc.identifier.other

dc.description.volume

dc.description.issue

Publisher

DOI

Abstract

Description

Keywords

Citation

URI

Collections

Endorsement

Review

Supplemented By

Referenced By